Filing Flows › Northwest Biotherapeutics (NWBO) › How it makes money
How Northwest Biotherapeutics (NWBO) makes money
Northwest Biotherapeutics (NWBO) made $807K of revenue in the second quarter 2026 (Q2 2026), +516% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $807K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $807K | +516% |
| Q1 2026 | $494K | +32% |
| Q4 2025 | $672K | +191% |
| Q3 2025 | $200K | -44% |
| Q2 2025 | $131K | -74% |
| Q1 2025 | $375K | +32% |
| Q4 2024 | $231K | -48% |
From Northwest Biotherapeutics' 10-Q filed Aug 14, 2026 (on EDGAR).
Questions
How does Northwest Biotherapeutics make money?
Northwest Biotherapeutics (NWBO) made $807K of revenue in the second quarter 2026 (Q2 2026), +516% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.